Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|1|3|271-288

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.1, Iss.3, 2006-11, pp. : 271-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Research Highlights: Genetic association of the dopamine receptor D3 Ser9Gly polymorphism with a DRD3 antagonist

By Lane Hsien-Yuan   Tsai Guochuan E   Lin Eugene  

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 631-632

Future Medicine

Access to resources Recommend Favorite

Structural features of GABAA receptor antagonists: pharmacophore modeling and 3D-QSAR studies

By Zhang Wei   Xia Shuang   Ye Jinjin   Tang Yun   Li Zhong   Zhu Weiping   Cheng Jiagao  

Medicinal Chemistry Research, Vol. 22, Iss. 12, 2013-12 ,pp. : 5961-5972

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning

By  

Molecular Neuropsychiatry, Vol. 2, Iss. 3, 2016-07 ,pp. : 124-132

Karger

Access to resources Recommend Favorite

Rotigotine is potent agonist at D1 receptors

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 4, 2015-02 ,pp. : 1124-1135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension

By Schroll S.   Arzt M.   Sebah D.   Stoelcker B.   Luchner A.   Budweiser S.   Blumberg F. C.   Pfeifer M.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 4, 2008-07 ,pp. : 270-276

Informa Healthcare

Access to resources Recommend Favorite